WHO Uterotonics for PPH Prevention: Quality and Accessibility

The presentation highlights the importance of accessibility of good quality uterotonics in low- and middle-income countries (LMIC) to manage PPH, which is the leading cause of maternal mortality. It also discusses the quality of oxytocin, a recommended uterotonic agent, and the need for its proper storage, transportation, and management in the cold chain (2-8°C) to ensure its effectiveness. Additionally, the presentation touches on the consequences of substandard oxytocin, including the risk of PPH, cesarean sections, and the need for healthcare providers to perceive the quality of oxytocin available in their settings.